Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy
Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patte...
Ausführliche Beschreibung
Autor*in: |
Bhat, Ganesh [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2013 |
---|
Schlagwörter: |
---|
Anmerkung: |
© Indian Society of Gastroenterology 2013 |
---|
Übergeordnetes Werk: |
Enthalten in: Indian Journal of Gastroenterology - Springer-Verlag, 2009, 32(2013), 5 vom: 21. März, Seite 297-301 |
---|---|
Übergeordnetes Werk: |
volume:32 ; year:2013 ; number:5 ; day:21 ; month:03 ; pages:297-301 |
Links: |
---|
DOI / URN: |
10.1007/s12664-013-0329-y |
---|
Katalog-ID: |
SPR026656108 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR026656108 | ||
003 | DE-627 | ||
005 | 20230519190200.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s12664-013-0329-y |2 doi | |
035 | |a (DE-627)SPR026656108 | ||
035 | |a (SPR)s12664-013-0329-y-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bhat, Ganesh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy |
264 | 1 | |c 2013 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Indian Society of Gastroenterology 2013 | ||
520 | |a Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patterns, and clinical epidemiology including 1-month mortality of SAIs among patients with cirrhosis. Methods Records of 600 patients with suspected SAI over a 4-year period were analyzed. Empirical cefotaxime/ceftriaxone was initiated in patients who had a neutrophil count >250/$ mm^{3} $. Treatment failure was defined by absence of clinical improvement and/or significant decrease in neutrophil count of ascites (<25 % of base line value) by 72 h of therapy. Results Seventy patients (11.6 %) had SAI, including 40 (57.1 %) culture-negative neutrocytic ascites (CNNA), 25 (35.8 %) spontaneous bacterial peritonitis (SBP), and five (7 %) monomicrobial non-neutrocytic bacterascites (MNB). Gram-negative bacilli (Klebsiella and E. coli) were the commonest organisms. The overall response rate to ceftriaxone was 62.8 % (44/70). Among culture-positive patients (SBP and MNB), sensitivity rates to ceftriaxone was 50 %, while it was 53.3 % for quinolones, 70 % for piperacillin–tazobactam, and 93.3 % for cefoperazone–sulbactam combination. Thirty-day mortality was lower for CNNA compared to SBP (20 % vs. 40 %, p < 0.001) and for patients with response compared to no response to first antibiotic (11.3 % vs. 53.8 %, p < 0.001). Conclusion The response of SAI to third-generation cephalosporins was low at our center. Cefoperazone–sulbactam could be a better alternative choice. | ||
650 | 4 | |a Antibiotic sensitivity |7 (dpeaa)DE-He213 | |
650 | 4 | |a Ascitic fluid culture |7 (dpeaa)DE-He213 | |
650 | 4 | |a Peritoneal infections |7 (dpeaa)DE-He213 | |
700 | 1 | |a Vandana, K. E. |4 aut | |
700 | 1 | |a Bhatia, Sumit |4 aut | |
700 | 1 | |a Suvarna, Deepak |4 aut | |
700 | 1 | |a Pai, Cannanore Ganesh |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Indian Journal of Gastroenterology |d Springer-Verlag, 2009 |g 32(2013), 5 vom: 21. März, Seite 297-301 |w (DE-627)SPR02665167X |7 nnns |
773 | 1 | 8 | |g volume:32 |g year:2013 |g number:5 |g day:21 |g month:03 |g pages:297-301 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s12664-013-0329-y |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 32 |j 2013 |e 5 |b 21 |c 03 |h 297-301 |
author_variant |
g b gb k e v ke kev s b sb d s ds c g p cg cgp |
---|---|
matchkey_str |
bhatganeshvandanakebhatiasumitsuvarnadee:2013----:pnaeuactcliifcinniecrhssatrooiapoienr |
hierarchy_sort_str |
2013 |
publishDate |
2013 |
allfields |
10.1007/s12664-013-0329-y doi (DE-627)SPR026656108 (SPR)s12664-013-0329-y-e DE-627 ger DE-627 rakwb eng Bhat, Ganesh verfasserin aut Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Indian Society of Gastroenterology 2013 Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patterns, and clinical epidemiology including 1-month mortality of SAIs among patients with cirrhosis. Methods Records of 600 patients with suspected SAI over a 4-year period were analyzed. Empirical cefotaxime/ceftriaxone was initiated in patients who had a neutrophil count >250/$ mm^{3} $. Treatment failure was defined by absence of clinical improvement and/or significant decrease in neutrophil count of ascites (<25 % of base line value) by 72 h of therapy. Results Seventy patients (11.6 %) had SAI, including 40 (57.1 %) culture-negative neutrocytic ascites (CNNA), 25 (35.8 %) spontaneous bacterial peritonitis (SBP), and five (7 %) monomicrobial non-neutrocytic bacterascites (MNB). Gram-negative bacilli (Klebsiella and E. coli) were the commonest organisms. The overall response rate to ceftriaxone was 62.8 % (44/70). Among culture-positive patients (SBP and MNB), sensitivity rates to ceftriaxone was 50 %, while it was 53.3 % for quinolones, 70 % for piperacillin–tazobactam, and 93.3 % for cefoperazone–sulbactam combination. Thirty-day mortality was lower for CNNA compared to SBP (20 % vs. 40 %, p < 0.001) and for patients with response compared to no response to first antibiotic (11.3 % vs. 53.8 %, p < 0.001). Conclusion The response of SAI to third-generation cephalosporins was low at our center. Cefoperazone–sulbactam could be a better alternative choice. Antibiotic sensitivity (dpeaa)DE-He213 Ascitic fluid culture (dpeaa)DE-He213 Peritoneal infections (dpeaa)DE-He213 Vandana, K. E. aut Bhatia, Sumit aut Suvarna, Deepak aut Pai, Cannanore Ganesh aut Enthalten in Indian Journal of Gastroenterology Springer-Verlag, 2009 32(2013), 5 vom: 21. März, Seite 297-301 (DE-627)SPR02665167X nnns volume:32 year:2013 number:5 day:21 month:03 pages:297-301 https://dx.doi.org/10.1007/s12664-013-0329-y lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 32 2013 5 21 03 297-301 |
spelling |
10.1007/s12664-013-0329-y doi (DE-627)SPR026656108 (SPR)s12664-013-0329-y-e DE-627 ger DE-627 rakwb eng Bhat, Ganesh verfasserin aut Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Indian Society of Gastroenterology 2013 Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patterns, and clinical epidemiology including 1-month mortality of SAIs among patients with cirrhosis. Methods Records of 600 patients with suspected SAI over a 4-year period were analyzed. Empirical cefotaxime/ceftriaxone was initiated in patients who had a neutrophil count >250/$ mm^{3} $. Treatment failure was defined by absence of clinical improvement and/or significant decrease in neutrophil count of ascites (<25 % of base line value) by 72 h of therapy. Results Seventy patients (11.6 %) had SAI, including 40 (57.1 %) culture-negative neutrocytic ascites (CNNA), 25 (35.8 %) spontaneous bacterial peritonitis (SBP), and five (7 %) monomicrobial non-neutrocytic bacterascites (MNB). Gram-negative bacilli (Klebsiella and E. coli) were the commonest organisms. The overall response rate to ceftriaxone was 62.8 % (44/70). Among culture-positive patients (SBP and MNB), sensitivity rates to ceftriaxone was 50 %, while it was 53.3 % for quinolones, 70 % for piperacillin–tazobactam, and 93.3 % for cefoperazone–sulbactam combination. Thirty-day mortality was lower for CNNA compared to SBP (20 % vs. 40 %, p < 0.001) and for patients with response compared to no response to first antibiotic (11.3 % vs. 53.8 %, p < 0.001). Conclusion The response of SAI to third-generation cephalosporins was low at our center. Cefoperazone–sulbactam could be a better alternative choice. Antibiotic sensitivity (dpeaa)DE-He213 Ascitic fluid culture (dpeaa)DE-He213 Peritoneal infections (dpeaa)DE-He213 Vandana, K. E. aut Bhatia, Sumit aut Suvarna, Deepak aut Pai, Cannanore Ganesh aut Enthalten in Indian Journal of Gastroenterology Springer-Verlag, 2009 32(2013), 5 vom: 21. März, Seite 297-301 (DE-627)SPR02665167X nnns volume:32 year:2013 number:5 day:21 month:03 pages:297-301 https://dx.doi.org/10.1007/s12664-013-0329-y lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 32 2013 5 21 03 297-301 |
allfields_unstemmed |
10.1007/s12664-013-0329-y doi (DE-627)SPR026656108 (SPR)s12664-013-0329-y-e DE-627 ger DE-627 rakwb eng Bhat, Ganesh verfasserin aut Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Indian Society of Gastroenterology 2013 Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patterns, and clinical epidemiology including 1-month mortality of SAIs among patients with cirrhosis. Methods Records of 600 patients with suspected SAI over a 4-year period were analyzed. Empirical cefotaxime/ceftriaxone was initiated in patients who had a neutrophil count >250/$ mm^{3} $. Treatment failure was defined by absence of clinical improvement and/or significant decrease in neutrophil count of ascites (<25 % of base line value) by 72 h of therapy. Results Seventy patients (11.6 %) had SAI, including 40 (57.1 %) culture-negative neutrocytic ascites (CNNA), 25 (35.8 %) spontaneous bacterial peritonitis (SBP), and five (7 %) monomicrobial non-neutrocytic bacterascites (MNB). Gram-negative bacilli (Klebsiella and E. coli) were the commonest organisms. The overall response rate to ceftriaxone was 62.8 % (44/70). Among culture-positive patients (SBP and MNB), sensitivity rates to ceftriaxone was 50 %, while it was 53.3 % for quinolones, 70 % for piperacillin–tazobactam, and 93.3 % for cefoperazone–sulbactam combination. Thirty-day mortality was lower for CNNA compared to SBP (20 % vs. 40 %, p < 0.001) and for patients with response compared to no response to first antibiotic (11.3 % vs. 53.8 %, p < 0.001). Conclusion The response of SAI to third-generation cephalosporins was low at our center. Cefoperazone–sulbactam could be a better alternative choice. Antibiotic sensitivity (dpeaa)DE-He213 Ascitic fluid culture (dpeaa)DE-He213 Peritoneal infections (dpeaa)DE-He213 Vandana, K. E. aut Bhatia, Sumit aut Suvarna, Deepak aut Pai, Cannanore Ganesh aut Enthalten in Indian Journal of Gastroenterology Springer-Verlag, 2009 32(2013), 5 vom: 21. März, Seite 297-301 (DE-627)SPR02665167X nnns volume:32 year:2013 number:5 day:21 month:03 pages:297-301 https://dx.doi.org/10.1007/s12664-013-0329-y lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 32 2013 5 21 03 297-301 |
allfieldsGer |
10.1007/s12664-013-0329-y doi (DE-627)SPR026656108 (SPR)s12664-013-0329-y-e DE-627 ger DE-627 rakwb eng Bhat, Ganesh verfasserin aut Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Indian Society of Gastroenterology 2013 Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patterns, and clinical epidemiology including 1-month mortality of SAIs among patients with cirrhosis. Methods Records of 600 patients with suspected SAI over a 4-year period were analyzed. Empirical cefotaxime/ceftriaxone was initiated in patients who had a neutrophil count >250/$ mm^{3} $. Treatment failure was defined by absence of clinical improvement and/or significant decrease in neutrophil count of ascites (<25 % of base line value) by 72 h of therapy. Results Seventy patients (11.6 %) had SAI, including 40 (57.1 %) culture-negative neutrocytic ascites (CNNA), 25 (35.8 %) spontaneous bacterial peritonitis (SBP), and five (7 %) monomicrobial non-neutrocytic bacterascites (MNB). Gram-negative bacilli (Klebsiella and E. coli) were the commonest organisms. The overall response rate to ceftriaxone was 62.8 % (44/70). Among culture-positive patients (SBP and MNB), sensitivity rates to ceftriaxone was 50 %, while it was 53.3 % for quinolones, 70 % for piperacillin–tazobactam, and 93.3 % for cefoperazone–sulbactam combination. Thirty-day mortality was lower for CNNA compared to SBP (20 % vs. 40 %, p < 0.001) and for patients with response compared to no response to first antibiotic (11.3 % vs. 53.8 %, p < 0.001). Conclusion The response of SAI to third-generation cephalosporins was low at our center. Cefoperazone–sulbactam could be a better alternative choice. Antibiotic sensitivity (dpeaa)DE-He213 Ascitic fluid culture (dpeaa)DE-He213 Peritoneal infections (dpeaa)DE-He213 Vandana, K. E. aut Bhatia, Sumit aut Suvarna, Deepak aut Pai, Cannanore Ganesh aut Enthalten in Indian Journal of Gastroenterology Springer-Verlag, 2009 32(2013), 5 vom: 21. März, Seite 297-301 (DE-627)SPR02665167X nnns volume:32 year:2013 number:5 day:21 month:03 pages:297-301 https://dx.doi.org/10.1007/s12664-013-0329-y lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 32 2013 5 21 03 297-301 |
allfieldsSound |
10.1007/s12664-013-0329-y doi (DE-627)SPR026656108 (SPR)s12664-013-0329-y-e DE-627 ger DE-627 rakwb eng Bhat, Ganesh verfasserin aut Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Indian Society of Gastroenterology 2013 Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patterns, and clinical epidemiology including 1-month mortality of SAIs among patients with cirrhosis. Methods Records of 600 patients with suspected SAI over a 4-year period were analyzed. Empirical cefotaxime/ceftriaxone was initiated in patients who had a neutrophil count >250/$ mm^{3} $. Treatment failure was defined by absence of clinical improvement and/or significant decrease in neutrophil count of ascites (<25 % of base line value) by 72 h of therapy. Results Seventy patients (11.6 %) had SAI, including 40 (57.1 %) culture-negative neutrocytic ascites (CNNA), 25 (35.8 %) spontaneous bacterial peritonitis (SBP), and five (7 %) monomicrobial non-neutrocytic bacterascites (MNB). Gram-negative bacilli (Klebsiella and E. coli) were the commonest organisms. The overall response rate to ceftriaxone was 62.8 % (44/70). Among culture-positive patients (SBP and MNB), sensitivity rates to ceftriaxone was 50 %, while it was 53.3 % for quinolones, 70 % for piperacillin–tazobactam, and 93.3 % for cefoperazone–sulbactam combination. Thirty-day mortality was lower for CNNA compared to SBP (20 % vs. 40 %, p < 0.001) and for patients with response compared to no response to first antibiotic (11.3 % vs. 53.8 %, p < 0.001). Conclusion The response of SAI to third-generation cephalosporins was low at our center. Cefoperazone–sulbactam could be a better alternative choice. Antibiotic sensitivity (dpeaa)DE-He213 Ascitic fluid culture (dpeaa)DE-He213 Peritoneal infections (dpeaa)DE-He213 Vandana, K. E. aut Bhatia, Sumit aut Suvarna, Deepak aut Pai, Cannanore Ganesh aut Enthalten in Indian Journal of Gastroenterology Springer-Verlag, 2009 32(2013), 5 vom: 21. März, Seite 297-301 (DE-627)SPR02665167X nnns volume:32 year:2013 number:5 day:21 month:03 pages:297-301 https://dx.doi.org/10.1007/s12664-013-0329-y lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 32 2013 5 21 03 297-301 |
language |
English |
source |
Enthalten in Indian Journal of Gastroenterology 32(2013), 5 vom: 21. März, Seite 297-301 volume:32 year:2013 number:5 day:21 month:03 pages:297-301 |
sourceStr |
Enthalten in Indian Journal of Gastroenterology 32(2013), 5 vom: 21. März, Seite 297-301 volume:32 year:2013 number:5 day:21 month:03 pages:297-301 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Antibiotic sensitivity Ascitic fluid culture Peritoneal infections |
isfreeaccess_bool |
false |
container_title |
Indian Journal of Gastroenterology |
authorswithroles_txt_mv |
Bhat, Ganesh @@aut@@ Vandana, K. E. @@aut@@ Bhatia, Sumit @@aut@@ Suvarna, Deepak @@aut@@ Pai, Cannanore Ganesh @@aut@@ |
publishDateDaySort_date |
2013-03-21T00:00:00Z |
hierarchy_top_id |
SPR02665167X |
id |
SPR026656108 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR026656108</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519190200.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12664-013-0329-y</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR026656108</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12664-013-0329-y-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bhat, Ganesh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Indian Society of Gastroenterology 2013</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patterns, and clinical epidemiology including 1-month mortality of SAIs among patients with cirrhosis. Methods Records of 600 patients with suspected SAI over a 4-year period were analyzed. Empirical cefotaxime/ceftriaxone was initiated in patients who had a neutrophil count >250/$ mm^{3} $. Treatment failure was defined by absence of clinical improvement and/or significant decrease in neutrophil count of ascites (<25 % of base line value) by 72 h of therapy. Results Seventy patients (11.6 %) had SAI, including 40 (57.1 %) culture-negative neutrocytic ascites (CNNA), 25 (35.8 %) spontaneous bacterial peritonitis (SBP), and five (7 %) monomicrobial non-neutrocytic bacterascites (MNB). Gram-negative bacilli (Klebsiella and E. coli) were the commonest organisms. The overall response rate to ceftriaxone was 62.8 % (44/70). Among culture-positive patients (SBP and MNB), sensitivity rates to ceftriaxone was 50 %, while it was 53.3 % for quinolones, 70 % for piperacillin–tazobactam, and 93.3 % for cefoperazone–sulbactam combination. Thirty-day mortality was lower for CNNA compared to SBP (20 % vs. 40 %, p < 0.001) and for patients with response compared to no response to first antibiotic (11.3 % vs. 53.8 %, p < 0.001). Conclusion The response of SAI to third-generation cephalosporins was low at our center. Cefoperazone–sulbactam could be a better alternative choice.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibiotic sensitivity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ascitic fluid culture</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Peritoneal infections</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vandana, K. E.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bhatia, Sumit</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suvarna, Deepak</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pai, Cannanore Ganesh</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Indian Journal of Gastroenterology</subfield><subfield code="d">Springer-Verlag, 2009</subfield><subfield code="g">32(2013), 5 vom: 21. März, Seite 297-301</subfield><subfield code="w">(DE-627)SPR02665167X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:32</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:5</subfield><subfield code="g">day:21</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:297-301</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12664-013-0329-y</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">32</subfield><subfield code="j">2013</subfield><subfield code="e">5</subfield><subfield code="b">21</subfield><subfield code="c">03</subfield><subfield code="h">297-301</subfield></datafield></record></collection>
|
author |
Bhat, Ganesh |
spellingShingle |
Bhat, Ganesh misc Antibiotic sensitivity misc Ascitic fluid culture misc Peritoneal infections Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy |
authorStr |
Bhat, Ganesh |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR02665167X |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut |
collection |
springer |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy Antibiotic sensitivity (dpeaa)DE-He213 Ascitic fluid culture (dpeaa)DE-He213 Peritoneal infections (dpeaa)DE-He213 |
topic |
misc Antibiotic sensitivity misc Ascitic fluid culture misc Peritoneal infections |
topic_unstemmed |
misc Antibiotic sensitivity misc Ascitic fluid culture misc Peritoneal infections |
topic_browse |
misc Antibiotic sensitivity misc Ascitic fluid culture misc Peritoneal infections |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Indian Journal of Gastroenterology |
hierarchy_parent_id |
SPR02665167X |
hierarchy_top_title |
Indian Journal of Gastroenterology |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)SPR02665167X |
title |
Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy |
ctrlnum |
(DE-627)SPR026656108 (SPR)s12664-013-0329-y-e |
title_full |
Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy |
author_sort |
Bhat, Ganesh |
journal |
Indian Journal of Gastroenterology |
journalStr |
Indian Journal of Gastroenterology |
lang_code |
eng |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
2013 |
contenttype_str_mv |
txt |
container_start_page |
297 |
author_browse |
Bhat, Ganesh Vandana, K. E. Bhatia, Sumit Suvarna, Deepak Pai, Cannanore Ganesh |
container_volume |
32 |
format_se |
Elektronische Aufsätze |
author-letter |
Bhat, Ganesh |
doi_str_mv |
10.1007/s12664-013-0329-y |
title_sort |
spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy |
title_auth |
Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy |
abstract |
Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patterns, and clinical epidemiology including 1-month mortality of SAIs among patients with cirrhosis. Methods Records of 600 patients with suspected SAI over a 4-year period were analyzed. Empirical cefotaxime/ceftriaxone was initiated in patients who had a neutrophil count >250/$ mm^{3} $. Treatment failure was defined by absence of clinical improvement and/or significant decrease in neutrophil count of ascites (<25 % of base line value) by 72 h of therapy. Results Seventy patients (11.6 %) had SAI, including 40 (57.1 %) culture-negative neutrocytic ascites (CNNA), 25 (35.8 %) spontaneous bacterial peritonitis (SBP), and five (7 %) monomicrobial non-neutrocytic bacterascites (MNB). Gram-negative bacilli (Klebsiella and E. coli) were the commonest organisms. The overall response rate to ceftriaxone was 62.8 % (44/70). Among culture-positive patients (SBP and MNB), sensitivity rates to ceftriaxone was 50 %, while it was 53.3 % for quinolones, 70 % for piperacillin–tazobactam, and 93.3 % for cefoperazone–sulbactam combination. Thirty-day mortality was lower for CNNA compared to SBP (20 % vs. 40 %, p < 0.001) and for patients with response compared to no response to first antibiotic (11.3 % vs. 53.8 %, p < 0.001). Conclusion The response of SAI to third-generation cephalosporins was low at our center. Cefoperazone–sulbactam could be a better alternative choice. © Indian Society of Gastroenterology 2013 |
abstractGer |
Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patterns, and clinical epidemiology including 1-month mortality of SAIs among patients with cirrhosis. Methods Records of 600 patients with suspected SAI over a 4-year period were analyzed. Empirical cefotaxime/ceftriaxone was initiated in patients who had a neutrophil count >250/$ mm^{3} $. Treatment failure was defined by absence of clinical improvement and/or significant decrease in neutrophil count of ascites (<25 % of base line value) by 72 h of therapy. Results Seventy patients (11.6 %) had SAI, including 40 (57.1 %) culture-negative neutrocytic ascites (CNNA), 25 (35.8 %) spontaneous bacterial peritonitis (SBP), and five (7 %) monomicrobial non-neutrocytic bacterascites (MNB). Gram-negative bacilli (Klebsiella and E. coli) were the commonest organisms. The overall response rate to ceftriaxone was 62.8 % (44/70). Among culture-positive patients (SBP and MNB), sensitivity rates to ceftriaxone was 50 %, while it was 53.3 % for quinolones, 70 % for piperacillin–tazobactam, and 93.3 % for cefoperazone–sulbactam combination. Thirty-day mortality was lower for CNNA compared to SBP (20 % vs. 40 %, p < 0.001) and for patients with response compared to no response to first antibiotic (11.3 % vs. 53.8 %, p < 0.001). Conclusion The response of SAI to third-generation cephalosporins was low at our center. Cefoperazone–sulbactam could be a better alternative choice. © Indian Society of Gastroenterology 2013 |
abstract_unstemmed |
Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patterns, and clinical epidemiology including 1-month mortality of SAIs among patients with cirrhosis. Methods Records of 600 patients with suspected SAI over a 4-year period were analyzed. Empirical cefotaxime/ceftriaxone was initiated in patients who had a neutrophil count >250/$ mm^{3} $. Treatment failure was defined by absence of clinical improvement and/or significant decrease in neutrophil count of ascites (<25 % of base line value) by 72 h of therapy. Results Seventy patients (11.6 %) had SAI, including 40 (57.1 %) culture-negative neutrocytic ascites (CNNA), 25 (35.8 %) spontaneous bacterial peritonitis (SBP), and five (7 %) monomicrobial non-neutrocytic bacterascites (MNB). Gram-negative bacilli (Klebsiella and E. coli) were the commonest organisms. The overall response rate to ceftriaxone was 62.8 % (44/70). Among culture-positive patients (SBP and MNB), sensitivity rates to ceftriaxone was 50 %, while it was 53.3 % for quinolones, 70 % for piperacillin–tazobactam, and 93.3 % for cefoperazone–sulbactam combination. Thirty-day mortality was lower for CNNA compared to SBP (20 % vs. 40 %, p < 0.001) and for patients with response compared to no response to first antibiotic (11.3 % vs. 53.8 %, p < 0.001). Conclusion The response of SAI to third-generation cephalosporins was low at our center. Cefoperazone–sulbactam could be a better alternative choice. © Indian Society of Gastroenterology 2013 |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA |
container_issue |
5 |
title_short |
Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy |
url |
https://dx.doi.org/10.1007/s12664-013-0329-y |
remote_bool |
true |
author2 |
Vandana, K. E. Bhatia, Sumit Suvarna, Deepak Pai, Cannanore Ganesh |
author2Str |
Vandana, K. E. Bhatia, Sumit Suvarna, Deepak Pai, Cannanore Ganesh |
ppnlink |
SPR02665167X |
mediatype_str_mv |
c |
isOA_txt |
false |
hochschulschrift_bool |
false |
doi_str |
10.1007/s12664-013-0329-y |
up_date |
2024-07-03T21:58:37.464Z |
_version_ |
1803596770799779840 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR026656108</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519190200.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12664-013-0329-y</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR026656108</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12664-013-0329-y-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bhat, Ganesh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Indian Society of Gastroenterology 2013</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Spontaneous ascitic fluid infection (SAI) is common in cirrhotic patients leading to significant morbidity and mortality. Third-generation cephalosporins are currently recommended as first-line therapy. We conducted a prospective study to determine bacterial etiology, susceptibility patterns, and clinical epidemiology including 1-month mortality of SAIs among patients with cirrhosis. Methods Records of 600 patients with suspected SAI over a 4-year period were analyzed. Empirical cefotaxime/ceftriaxone was initiated in patients who had a neutrophil count >250/$ mm^{3} $. Treatment failure was defined by absence of clinical improvement and/or significant decrease in neutrophil count of ascites (<25 % of base line value) by 72 h of therapy. Results Seventy patients (11.6 %) had SAI, including 40 (57.1 %) culture-negative neutrocytic ascites (CNNA), 25 (35.8 %) spontaneous bacterial peritonitis (SBP), and five (7 %) monomicrobial non-neutrocytic bacterascites (MNB). Gram-negative bacilli (Klebsiella and E. coli) were the commonest organisms. The overall response rate to ceftriaxone was 62.8 % (44/70). Among culture-positive patients (SBP and MNB), sensitivity rates to ceftriaxone was 50 %, while it was 53.3 % for quinolones, 70 % for piperacillin–tazobactam, and 93.3 % for cefoperazone–sulbactam combination. Thirty-day mortality was lower for CNNA compared to SBP (20 % vs. 40 %, p < 0.001) and for patients with response compared to no response to first antibiotic (11.3 % vs. 53.8 %, p < 0.001). Conclusion The response of SAI to third-generation cephalosporins was low at our center. Cefoperazone–sulbactam could be a better alternative choice.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibiotic sensitivity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ascitic fluid culture</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Peritoneal infections</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vandana, K. E.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bhatia, Sumit</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suvarna, Deepak</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pai, Cannanore Ganesh</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Indian Journal of Gastroenterology</subfield><subfield code="d">Springer-Verlag, 2009</subfield><subfield code="g">32(2013), 5 vom: 21. März, Seite 297-301</subfield><subfield code="w">(DE-627)SPR02665167X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:32</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:5</subfield><subfield code="g">day:21</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:297-301</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12664-013-0329-y</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">32</subfield><subfield code="j">2013</subfield><subfield code="e">5</subfield><subfield code="b">21</subfield><subfield code="c">03</subfield><subfield code="h">297-301</subfield></datafield></record></collection>
|
score |
7.3970747 |